INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
In this study glycyrrhizic acid derivatives has been taken, since Glycyrrhiza glabra has excellent antiviral activity and has been used since ancient times. An instantaneously qualifying technique is utilized to discover a natural antiviral medicine that will be helpful in the treatment of various viral infections as well as the prevention of several pandemic diseases SARS COVID 19 and influenza A/h1n1. For molecular docking study main targeting protease (Pdb id: 6i3h) is gaining importance in designing of antiviral drug active against H1N1. An attempt has been made to suggest an in silico computational relationship between glycyrrhizic acid derivative and an influenza protein 6i3h. The docking score were calculated by glide based docking and best docking score found with some of the glycyrrhizic acid analouges.
Keywords:
GL, 6I3H, H1N1, GA, HPLC, 2D and 3D, CD, Å
Cite Article:
"MOLECULAR DOCKING OF SELECTED BIOACTIVE COMPOUNDS FROM GLYCRRYHIZA GLABRA", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.a587-a595, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211065.pdf
Downloads:
000118755
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn